Find a psychedelic-integration therapist

What good integration actually looks like

Integration is not a vague spiritual concept. In the published research it refers to a set of structured practices in the 1–12 weeks after a psychedelic session that help a participant translate the experience into durable behavior change. The Bathje et al. (2022) framework operationalizes it across seven domains — cognitive, emotional, physical, relational, spiritual, behavioral, and social/environmental. See the full integration therapy guide for the framework in detail.

In practice, integration typically involves structured sessions where a therapist helps a client revisit, contextualize, and apply insights from a psychedelic experience. This might include processing difficult emotional material that surfaced during the session, identifying behavioral patterns the client wants to change, developing a plan for implementing those changes in daily life, and monitoring for delayed psychological effects such as depersonalization or anxiety. The therapist's role is not to interpret the experience for the client but to provide a safe, clinically informed framework for the client to make meaning on their own terms.

The credential landscape in 2026

There is no single nationally recognized credential for psychedelic-integration therapy. The field sits at the intersection of several existing professional frameworks, and the credential landscape is evolving rapidly:

• State licensure remains the foundation. A psychedelic-integration therapist should hold a valid state mental-health license — LCSW, LPC, LMFT, PsyD, PhD, MD/DO, or NP. This license is what enables them to provide therapy (as opposed to coaching), bill insurance where applicable, and be held to professional ethics standards with a complaint process.
• Certificate programs from institutions like Fluence, CIIS, Naropa/Memoru, IPI, and Polaris add psychedelic-specific training on top of existing licensure. These programs vary in length (40–300+ hours), clinical practicum requirements, and focus areas. A certificate alone — without underlying state licensure — does not make someone a therapist.
• Oregon and Colorado psilocybin facilitator licenses are a separate category. Oregon's Measure 109 (operational since 2023) and Colorado's Proposition 122 (implementation underway) created state-level facilitator licensing for psilocybin services. These facilitators are not required to hold mental-health licenses, and their scope is facilitation during psilocybin sessions, not ongoing therapy.
• Ketamine-specific training is the most clinically established pathway because ketamine is a legal, FDA-approved anesthetic that licensed prescribers can use off-label for psychiatric conditions. Programs from Polaris, IPI, and Sage focus specifically on ketamine-assisted psychotherapy (KAP) protocols.

Talking with an integration therapist about a psychedelic experience is legal everywhere in the US — the therapy relationship itself isn't the regulated part. What varies by state is the substance: ketamine is federally legal to prescribe, psilocybin has licensed regulated access only in Oregon and Colorado, and MDMA and classic psychedelics remain Schedule I outside of clinical trials. See the legal status by state tool or the psychedelic law hub for where you live.

Looking for a psychedelic integration coach instead? Coaching is a distinct, unlicensed category — a coach is not required to hold a state mental-health license, isn't bound by a licensing board's ethics/complaint process, and generally can't bill insurance. It can still be useful for goal-setting and accountability work. But if you're processing trauma, a diagnosed mental-health condition, or a difficult experience, start with a licensed therapist from the directories above rather than a coach.

Outside the United States

Everything above is scoped to the US. The licensure list, the Oregon and Colorado facilitator programs, and the "legal everywhere" language all describe US law. Other countries use different credential titles and different rules.

Canada has a named pathway. A licensed physician or nurse practitioner can request case-by-case access to a psychedelic through Health Canada's Special Access Program. Our Health Canada SAP guide explains who qualifies.

Australia has one too. Only a psychiatrist approved as a TGA Authorised Prescriber can prescribe psilocybin or MDMA for two approved conditions. Our Australia psychedelic rescheduling guide covers how that program works.

This site does not yet track country-specific legal frameworks or provider directories. That includes the UK, Germany, the Netherlands, Dubai, Thailand, and New Zealand. The Fluence and CIIS directories above include some internationally trained practitioners.

Neither directory lets you filter by country. Treat a listing there as a starting point to verify, not a local recommendation.

Questions worth asking a prospective therapist

1. What is your training? Specific program + year of completion is the answer you want. “I'm experienced with psychedelics” alone is not a credential.
2. What is your license? Integration therapy should be provided by a state-licensed mental-health professional when it is therapy (as opposed to coaching). Ask for their license number and verify it with the relevant state board.
3. How do you handle my specific medication regimen? Especially SSRIs, SNRIs, lithium, MAOIs, and stimulants. Interactions with psychedelics range from reduced efficacy (SSRIs blunting psilocybin effects) to life-threatening (MAOIs with ayahuasca analogs, lithium with classical psychedelics). A qualified therapist should be comfortable discussing these interactions and coordinating with your prescriber.
4. What’s your approach to difficult content? Childhood trauma, spiritual crisis, and ego-dissolution distress each benefit from different therapeutic frameworks. Ask whether they use a specific modality — IFS, somatic experiencing, EMDR, ACT, or psychodynamic approaches — and whether they have experience with challenging psychedelic experiences specifically.
5. Session cadence. A common structure is 1–2 preparation sessions, a dosing session (if applicable and legal), then 3–6 integration sessions over 8–12 weeks. Be wary of providers who skip preparation or offer only a single follow-up session.
6. Do you facilitate the dosing session yourself, or refer out? Most US therapists cannot legally provide the dosing session for anything but ketamine. A therapist who offers psilocybin or MDMA dosing outside of a clinical trial, approved state program (Oregon, Colorado), or legal jurisdiction is operating outside the law.
7. What is your fee structure? Integration therapy sessions typically cost $150–$300 per session. Some therapists offer sliding-scale rates. Ketamine-assisted psychotherapy packages (including the medication) typically range from $400–$800 per session. Be cautious of providers charging significantly above market rates or requiring large upfront payments for multi-session packages.
8. What happens if I have a difficult experience? Ask whether they have a between-session contact policy, crisis protocols, and whether they coordinate with other members of your care team (psychiatrist, primary care provider) if needed.
9. How confidential are my records? A licensed therapist's notes carry the same HIPAA and state privacy protections as any other mental-health record, with the usual narrow exceptions (imminent danger to self or others, court subpoena, mandated reporting). That confidentiality does not extend to what you disclose about obtaining or using an illegal substance outside a licensed program. A therapist cannot promise anonymity for conduct they are separately obligated to handle under mandatory-reporting rules. Ask directly what they document and what stays out of the chart.

Red flags to watch for

The psychedelic therapy space is growing faster than regulatory oversight, which means the range of practitioner quality is wide. Specific warning signs that should prompt you to look elsewhere:

• Cure claims. No ethical provider should promise that psychedelic therapy will cure depression, PTSD, addiction, or any other condition. The evidence supports the potential for meaningful benefit in some people under supported conditions — not guaranteed outcomes.
• Pressure to use specific substances. A therapist who pushes you toward a particular psychedelic without thorough screening is prioritizing the experience over your safety.
• No screening or medical history review. Responsible providers screen for personal and family history of psychotic disorders, bipolar disorder, cardiac conditions, and current medications before any psychedelic work.
• Sexual or physical boundary violations. The vulnerability of psychedelic states makes boundary violations especially harmful. Any sexual contact, inappropriate touch, or romantic suggestion during or around sessions is a serious ethical violation.
• Discouragement from outside support. A provider who discourages you from seeing other therapists, sharing your experience with trusted people, or maintaining existing medical relationships is isolating you — a hallmark of unethical practice.
• Underground dosing presented as therapy. Providers who offer illegal substances outside of approved trials or state programs while calling it "therapy" expose both themselves and their clients to legal and safety risks.